These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 19105214)

  • 1. Immune manipulation of advanced breast cancer: an interpretative model of the relationship between immune system and tumor cell biology.
    Nicolini A; Carpi A
    Med Res Rev; 2009 May; 29(3):436-71. PubMed ID: 19105214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intratumoral cytokines and tumor cell biology determine spontaneous breast cancer-specific immune responses and their correlation to prognosis.
    Domschke C; Schuetz F; Ge Y; Seibel T; Falk C; Brors B; Vlodavsky I; Sommerfeldt N; Sinn HP; Kühnle MC; Schneeweiss A; Scharf A; Sohn C; Schirrmacher V; Moldenhauer G; Momburg F; Beckhove P
    Cancer Res; 2009 Nov; 69(21):8420-8. PubMed ID: 19843863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor apoptotic bodies inhibit CTL responses and antitumor immunity via membrane-bound transforming growth factor-beta1 inducing CD8+ T-cell anergy and CD4+ Tr1 cell responses.
    Xie Y; Bai O; Yuan J; Chibbar R; Slattery K; Wei Y; Deng Y; Xiang J
    Cancer Res; 2009 Oct; 69(19):7756-66. PubMed ID: 19789353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal of tumor-induced immunosuppression: a new approach to cancer therapy.
    Wojtowicz-Praga S
    J Immunother; 1997 May; 20(3):165-77. PubMed ID: 9181454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-inflammatory effects of plumbagin are mediated by inhibition of NF-kappaB activation in lymphocytes.
    Checker R; Sharma D; Sandur SK; Khanam S; Poduval TB
    Int Immunopharmacol; 2009 Jul; 9(7-8):949-58. PubMed ID: 19374955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of transforming growth factor-beta-mediated immunosuppression in tumor-draining lymph nodes augments antitumor responses by various immunologic cell types.
    Fujita T; Teramoto K; Ozaki Y; Hanaoka J; Tezuka N; Itoh Y; Asai T; Fujino S; Kontani K; Ogasawara K
    Cancer Res; 2009 Jun; 69(12):5142-50. PubMed ID: 19491278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amplifying cancer vaccine responses by modifying pathogenic gene programs in tumor cells.
    Spaner DE
    J Leukoc Biol; 2004 Aug; 76(2):338-51. PubMed ID: 15277580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human epithelial ovarian carcinoma cell-derived cytokines cooperatively induce activated CD4+CD25-CD45RA+ naïve T cells to express forkhead box protein 3 and exhibit suppressive ability in vitro.
    Zhao X; Ye F; Chen L; Lu W; Xie X
    Cancer Sci; 2009 Nov; 100(11):2143-51. PubMed ID: 19673890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autologous dendritic cells loaded with apoptotic tumor cells induce T cell-mediated immune responses against breast cancer in vitro.
    Delirezh N; Moazzeni SM; Shokri F; Shokrgozar MA; Atri M; Kokhaei P
    Cell Immunol; 2009; 257(1-2):23-31. PubMed ID: 19306994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Helenalin suppresses essential immune functions of activated CD4+ T cells by multiple mechanisms.
    Berges C; Fuchs D; Opelz G; Daniel V; Naujokat C
    Mol Immunol; 2009 Sep; 46(15):2892-901. PubMed ID: 19656571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of Gd@C82(OH)22 nanoparticles on the release of Th1/Th2 cytokines and induction of TNF-alpha mediated cellular immunity.
    Liu Y; Jiao F; Qiu Y; Li W; Lao F; Zhou G; Sun B; Xing G; Dong J; Zhao Y; Chai Z; Chen C
    Biomaterials; 2009 Aug; 30(23-24):3934-45. PubMed ID: 19403166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and characterization of Foxp3(+) gammadelta T cells in mouse and human.
    Kang N; Tang L; Li X; Wu D; Li W; Chen X; Cui L; Ba D; He W
    Immunol Lett; 2009 Aug; 125(2):105-13. PubMed ID: 19539651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunologic approaches to breast cancer treatment.
    Sabel MS; Nehs MA
    Surg Oncol Clin N Am; 2005 Jan; 14(1):1-31, v. PubMed ID: 15541997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-educated CD11bhighIalow regulatory dendritic cells suppress T cell response through arginase I.
    Liu Q; Zhang C; Sun A; Zheng Y; Wang L; Cao X
    J Immunol; 2009 May; 182(10):6207-16. PubMed ID: 19414774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of electroacupuncture on TH1/TH2 cytokine mRNA expression and mitogen-activated protein kinase signaling pathways in the splenic T cells of traumatized rats.
    Wang K; Wu H; Wang G; Li M; Zhang Z; Gu G
    Anesth Analg; 2009 Nov; 109(5):1666-73. PubMed ID: 19843806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular endothelial growth factor-induced chemotaxis and IL-10 from T cells.
    Shin JY; Yoon IH; Kim JS; Kim B; Park CG
    Cell Immunol; 2009; 256(1-2):72-8. PubMed ID: 19249018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colon polyps and cytokines: emerging immunological mechanisms.
    Jacobson-Brown P; Neuman MG
    Rom J Gastroenterol; 2003 Sep; 12(3):207-14. PubMed ID: 14502322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toll-like receptor 2 mediates invasion via activating NF-kappaB in MDA-MB-231 breast cancer cells.
    Xie W; Wang Y; Huang Y; Yang H; Wang J; Hu Z
    Biochem Biophys Res Commun; 2009 Feb; 379(4):1027-32. PubMed ID: 19141294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A key regulatory role of the transcription factor NFATc2 in bronchial adenocarcinoma via CD8+ T lymphocytes.
    Maxeiner JH; Karwot R; Sauer K; Scholtes P; Boross I; Koslowski M; Türeci O; Wiewrodt R; Neurath MF; Lehr HA; Finotto S
    Cancer Res; 2009 Apr; 69(7):3069-76. PubMed ID: 19318584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Constitutive NF-kappaB activation in colorectal carcinoma plays a key role in angiogenesis, promoting tumor growth.
    Sakamoto K; Maeda S; Hikiba Y; Nakagawa H; Hayakawa Y; Shibata W; Yanai A; Ogura K; Omata M
    Clin Cancer Res; 2009 Apr; 15(7):2248-58. PubMed ID: 19276252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.